Cargando…

Putative IL-10 Low Producer Genotypes Are Associated with a Favourable Etanercept Response in Patients with Rheumatoid Arthritis

Outcome predictors of biologic therapeutic drugs like TNF inhibitors are of interest since side effects like serious infections or malignancy cannot be completely ruled out. Response rates are heterogeneous. The present study addressed the question whether in patients with rheumatoid arthritis (RA)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schotte, Heiko, Schlüter, Bernhard, Schmidt, Hartmut, Gaubitz, Markus, Drynda, Susanne, Kekow, Jörn, Willeke, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4479553/ https://www.ncbi.nlm.nih.gov/pubmed/26107717 http://dx.doi.org/10.1371/journal.pone.0130907

Ejemplares similares

Molecular discrimination of responders and nonresponders to anti-TNFalpha therapy in rheumatoid arthritis by etanercept
por: Koczan, Dirk, et al.
Publicado: (2008)

Mycophenolate sodium treatment in patients with primary Sjögren syndrome: a pilot trial
por: Willeke, Peter, et al.
Publicado: (2007)

Increased serum levels of macrophage migration inhibitory factor in patients with primary Sjögren's syndrome
por: Willeke, Peter, et al.
Publicado: (2007)

Long-term persistence and effects of fetal microchimerisms on disease onset and status in a cohort of women with rheumatoid arthritis and systemic lupus erythematosus
por: Kekow, Marianne, et al.
Publicado: (2013)

Complex genetic predisposition in adult and juvenile rheumatoid arthritis
por: Miterski, Bianca, et al.
Publicado: (2004)

Modulation of the gene expression pattern in peripheral blood mononuclear cells by biologicals in rheumatoid arthritis
por: Kekow, J, et al.
Publicado: (2003)

Differential Effect of Cobalt and Chromium Ions as Well as CoCr Particles on the Expression of Osteogenic Markers and Osteoblast Function
por: Drynda, Andreas, et al.
Publicado: (2018)

Comparative study of Interleukin-18 (IL-18) serum levels in adult onset Still’s disease (AOSD) and systemic onset juvenile idiopathic arthritis (sJIA) and its use as a biomarker for diagnosis and evaluation of disease activity
por: Kudela, Holger, et al.
Publicado: (2019)

Efficacy, safety and patient-reported outcomes of combination etanercept and sulfasalazine versus etanercept alone in patients with rheumatoid arthritis: a double-blind randomised 2-year study
por: Combe, B, et al.
Publicado: (2008)

Etanercept in the treatment of rheumatoid arthritis
por: Haraoui, Boulos, et al.
Publicado: (2007)

Etanercept for Treating Rheumatoid Arthritis
por: Moreland, Larry W
Publicado: (2000)

Safety of etanercept in elderly subjects with rheumatoid arthritis
por: Lurati, Alfredomaria, et al.
Publicado: (2010)

Optimal dose of etanercept in the treatment of rheumatoid arthritis
por: Curtis, Elizabeth Mary, et al.
Publicado: (2014)

Rheumatoid Meningitis Occurring during Etanercept Treatment
por: Tsuzaki, Koji, et al.
Publicado: (2017)

Treatment of Rheumatoid Arthritis with Biologic DMARDS (Rituximab and Etanercept)
por: Gashi, Afrim A., et al.
Publicado: (2014)

Review of Biosimilar Trials and Data on Etanercept in Rheumatoid Arthritis
por: Chadwick, Laura, et al.
Publicado: (2018)

Changes in Plasma IL-6, Plasma VEGF and Serum YKL-40 During Treatment with Etanercept and Methotrexate or Etanercept Alone in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy
por: Knudsen, Lene Surland, et al.
Publicado: (2009)

Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFα inhibitors and rituximab
por: Listing, Joachim, et al.
Publicado: (2015)

Farm Exposure as a Differential Risk Factor in ANCA-Associated Vasculitis
por: Willeke, P., et al.
Publicado: (2015)

Etanercept originator versus etanercept biosimilar for the treatment of rheumatoid arthritis as a first biologic: results from the BSRBR-RA
por: Kearsley-Fleet, Lianne, et al.
Publicado: (2023)

Update on the use of etanercept across a spectrum of rheumatoid disorders
por: Combe, Bernard
Publicado: (2008)

Methotrexate alone and methotrexate combined with etanercept in treatment of rheumatoid arthritis
por: Rexhepi, Sylejman, et al.
Publicado: (2012)

Effectiveness of dose reduction of etanercept and adalimumab in patients with rheumatoid arthritis
por: Martínez-Pérez, Rosalía, et al.
Publicado: (2011)

Full dose, reduced dose or discontinuation of etanercept in rheumatoid arthritis
por: van Vollenhoven, Ronald F, et al.
Publicado: (2016)

A Pilot Dose‐Finding Study of Etanercept in Rheumatoid Arthritis
por: Breedveld, Ferdinand C., et al.
Publicado: (2017)

Microneedle-Assisted Transdermal Delivery of Etanercept for Rheumatoid Arthritis Treatment
por: Cao, Jian, et al.
Publicado: (2019)

Etanercept in the treatment of Graves’ ophthalmopathy with primary hypothyroidism and rheumatoid arthritis
por: BOSKOVIC, OLIVERA, et al.
Publicado: (2020)

Etanercept or Methotrexate Withdrawal in Rheumatoid Arthritis Patients in Sustained Remission
por: Curtis, Jeffrey R., et al.
Publicado: (2021)

Obesity reduces the real-world effectiveness of cytokine-targeted but not cell-targeted disease-modifying agents in rheumatoid arthritis
por: Schäfer, Martin, et al.
Publicado: (2020)

Postmarketing surveillance of safety and effectiveness of etanercept in Japanese patients with rheumatoid arthritis
por: Koike, Takao, et al.
Publicado: (2011)

Etanercept-Induced Systemic Lupus Erythematosus in a Patient with Rheumatoid Arthritis
por: Kang, Min-Jung, et al.
Publicado: (2006)

Adenoviral Pneumonia During Etanercept Treatment in a Patient with Rheumatoid Arthritis
por: Kang, Min-Jung, et al.
Publicado: (2007)

Etanercept may induce neurosarcoidosis in a patient treated for rheumatoid arthritis
por: Durel, Cécile-Audrey, et al.
Publicado: (2013)

Etanercept-Induced Pityriasis Lichenoides Chronica in a Patient with Rheumatoid Arthritis
por: Echeverri, Andrés F., et al.
Publicado: (2015)

Alopecia Universalis in a Case of Rheumatoid Arthritis after Treatment with Etanercept
por: Kandpal, Renu
Publicado: (2019)

Differential Methylation as a Biomarker of Response to Etanercept in Patients With Rheumatoid Arthritis
por: Plant, Darren, et al.
Publicado: (2016)

Casual effect of methotrexate+etanercept/infliximab on survival of patients with rheumatoid arthritis
por: Akhlaghi, Saeed, et al.
Publicado: (2019)

Dermatomyositis–lupuslike syndrome overlap under treatment with etanercept for rheumatoid arthritis
por: Lyakhovitsky, Anna, et al.
Publicado: (2020)

The effective threshold dose of etanercept in patients with methotrexate-resistant rheumatoid arthritis
por: Chen, Fangfang, et al.
Publicado: (2023)

Corrigendum to: Obesity reduces the real-world effectiveness of cytokine-targeted but not cell-targeted disease-modifying agents in rheumatoid arthritis
por: Schäfer, Martin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_f7ektn8b5c44g0mjk2e4350n4f